Methyldopa injection labels and packages: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Methyldopa#Package and Label Display Panel]]
{{Methyldopa}}
{{CMG}}; {{AE}} {{AK}}
 
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - Container
 
NDC 0517-8905-10
 
METHYLDOPATE HCl
INJECTION, USP
 
250 mg/5 mL (50 mg/mL)
 
5 mL SINGLE DOSE VIAL
 
FOR IV USE AFTER DILUTION
 
Rx Only
 
AMERICAN REGENT, INC.
SHIRLEY, NY  11967
 
{|
| [[image:methyldopa4.jpg|400px|thumb]]
|}
 
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - Carton
 
PRINCIPAL DISPLAY PANEL – Carton
 
METHYLDOPATE HCl
INJECTION, USP
 
250 mg/5 mL (50 mg/mL)
 
NDC 0517-8905-10
 
10 x 5 mL
SINGLE DOSE VIALS
 
FOR INTRAVENOUS USE AFTER DILUTION
 
Rx Only
 
Each mL contains: Methyldopate HCl 50 mg, Citric Acid (Anhydrous) 5 mg, Edetate Disodium 0.5 mg, Monothioglycerol 2 mg, Water for Injection q.s. Methylparaben 1.5 mg and Propylparaben 0.2 mg added as preservatives, Sodium Bisulfite 3.2 mg added as an antioxidant. pH adjusted with Sodium Hydroxide and/or Hydrochloric Acid.
DISCARD UNUSED PORTION.
Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) (See USP Controlled Room Temperature).
Directions for Use: See Package Insert.
 
AMERICAN
REGENT, INC.
SHIRLEY, NY 11967
 
Rev. 11/05
 
{|
| [[aimge:methyldopa5.jpg|400px|thumb]]
|}
 
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = METHYLDOPATE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5f25053-a9f3-48b9-a412-078f5ee942fd | publisher =  | date =  | accessdate = 10 March 2014 }}</ref>
 
 
 
 
 
==References==
 
{{Reflist|2}}
 
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 00:12, 22 July 2014